+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Sjogrens Syndrome Therapeutics Market 2021-2025- Product Image

Global Sjogrens Syndrome Therapeutics Market 2021-2025

  • ID: 5309573
  • Report
  • March 2021
  • Region: Global
  • 120 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • AbbVie Inc.
  • ADVANZ PHARMA Corp. Ltd.
  • Biogen Inc.
  • Bristol-Myers Squibb Co.
  • Daiichi Sankyo Co. Ltd.
  • Hikma Pharmaceuticals Plc
  • MORE
Global Sjogrens Syndrome Therapeutics Market 2021-2025

The publisher has been monitoring the sjogrens syndrome therapeutics market and it is poised to grow by $ 287.68 mn during 2021-2025 progressing at a CAGR of 4% during the forecast period. The report on sjogrens syndrome therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the strong drug pipeline, high prevalence and incidence of Sjogren's syndrome, and initiatives and expected approvals of products. In addition, strong drug pipeline is anticipated to boost the growth of the market as well.

The sjogrens syndrome therapeutics market analysis includes type segment and geographical landscape.

The sjogrens syndrome therapeutics market is segmented as below:

By Type
  • primary Sjogren's syndrome
  • secondary Sjogren's syndrome
By Geographical Landscapes
  • North America
  • Europe
  • Asia
  • ROW
This study identifies the growing development of biologics as one of the prime reasons driving the sjogrens syndrome therapeutics market growth during the next few years. Also, increasing diagnostic tests and biomarkers and rising number of awareness programs will lead to sizable demand in the market.

The report on sjogrens syndrome therapeutics market covers the following areas:
  • Sjogrens syndrome therapeutics market sizing
  • Sjogrens syndrome therapeutics market forecast
  • Sjogrens syndrome therapeutics market industry analysis
The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading sjogrens syndrome therapeutics market vendors that include AbbVie Inc., ADVANZ PHARMA Corp. Ltd., Biogen Inc., Bristol-Myers Squibb Co., Daiichi Sankyo Co. Ltd., Hikma Pharmaceuticals Plc, Johnson & Johnson, Novartis AG, Sanofi SA, and Sun Pharmaceutical Industries Ltd.. Also, the sjogrens syndrome therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • AbbVie Inc.
  • ADVANZ PHARMA Corp. Ltd.
  • Biogen Inc.
  • Bristol-Myers Squibb Co.
  • Daiichi Sankyo Co. Ltd.
  • Hikma Pharmaceuticals Plc
  • MORE
Executive Summary
  • Market Overview
Market Landscape
  • Market ecosystem
  • Value chain analysis
Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2020
  • Market outlook: Forecast for 2020 - 2025
Five Forces Analysis
  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
Market Segmentation by Type
  • Market segments
  • Comparison by Type
  • Primary Sjogren's syndrome - Market size and forecast 2020-2025
  • Secondary Sjogren's syndrome - Market size and forecast 2020-2025
  • Market opportunity by Type
Customer Landscape

Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2020-2025
  • Europe - Market size and forecast 2020-2025
  • Asia - Market size and forecast 2020-2025
  • ROW - Market size and forecast 2020-2025
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends
Vendor Landscape
  • Overview
  • Vendor landscape
  • Landscape disruption
Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • AbbVie Inc.
  • ADVANZ PHARMA Corp. Ltd.
  • Biogen Inc.
  • Bristol-Myers Squibb Co.
  • Daiichi Sankyo Co. Ltd.
  • Hikma Pharmaceuticals Plc
  • Johnson & Johnson
  • Novartis AG
  • Sanofi SA
  • Sun Pharmaceutical Industries Ltd.
Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations
List of Exhibits
  • Key Finding 1
  • Key Finding 2
  • Key Finding 3
  • Key Finding 5
  • Key Finding 6
  • Key Finding 7
  • Key Finding 8
  • Parent market
  • Market characteristics
  • Offerings of vendors included in the market definition
  • Market segments
  • Global - Market size and forecast 2020 - 2025 ($ million)
  • Global market: Year-over-year growth 2020 - 2025 (%)
  • Five forces analysis 2020 & 2025
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition - Five forces 2020
  • Customer landscape
  • Impact of drivers and challenges
  • Vendor landscape
  • Landscape disruption
  • Industry risks
  • Vendors covered
  • Market positioning of vendors
  • AbbVie Inc. - Overview
  • AbbVie Inc. - Business segments
  • AbbVie Inc. - Key offerings
  • AbbVie Inc. - Key customers
  • AbbVie Inc. - Segment focus
  • ADVANZ PHARMA Corp. Ltd. - Overview
  • ADVANZ PHARMA Corp. Ltd. - Business segments
  • ADVANZ PHARMA Corp. Ltd. - Key offerings
  • ADVANZ PHARMA Corp. Ltd. - Key customers
  • ADVANZ PHARMA Corp. Ltd. - Segment focus
  • Biogen Inc. - Overview
  • Biogen Inc. - Business segments
  • Biogen Inc. - Key offerings
  • Biogen Inc. - Key customers
  • Biogen Inc. - Segment focus
  • Bristol-Myers Squibb Co. - Overview
  • Bristol-Myers Squibb Co. - Product and service
  • Bristol-Myers Squibb Co. - Key offerings
  • Bristol-Myers Squibb Co. - Key customers
  • Bristol-Myers Squibb Co. - Segment focus
  • Daiichi Sankyo Co. Ltd. - Overview
  • Daiichi Sankyo Co. Ltd. - Business segments
  • Daiichi Sankyo Co. Ltd. - Key offerings
  • Daiichi Sankyo Co. Ltd. - Key customers
  • Daiichi Sankyo Co. Ltd. - Segment focus
  • Hikma Pharmaceuticals Plc - Overview
  • Hikma Pharmaceuticals Plc - Business segments
  • Hikma Pharmaceuticals Plc - Key offerings
  • Hikma Pharmaceuticals Plc - Key customers
  • Hikma Pharmaceuticals Plc - Segment focus
  • Johnson & Johnson - Overview
  • Johnson & Johnson - Business segments
  • Johnson & Johnson - Key offerings
  • Johnson & Johnson - Key customers
  • Johnson & Johnson - Segment focus
  • Novartis AG - Overview
  • Novartis AG - Business segments
  • Novartis AG - Key offerings
  • Novartis AG - Key customers
  • Novartis AG - Segment focus
  • Sanofi SA - Overview
  • Sanofi SA - Business segments
  • Sanofi SA - Key offerings
  • Sanofi SA - Key customers
  • Sanofi SA - Segment focus
  • Sun Pharmaceutical Industries Ltd. - Overview
  • Sun Pharmaceutical Industries Ltd. - Business segments
  • Sun Pharmaceutical Industries Ltd. - Key offerings
  • Sun Pharmaceutical Industries Ltd. - Key customers
  • Sun Pharmaceutical Industries Ltd. - Segment focus
  • Currency conversion rates for US$
  • Research Methodology
  • Validation techniques employed for market sizing
  • Information sources
  • List of abbreviations
Note: Product cover images may vary from those shown
3 of 5

FEATURED COMPANIES

  • AbbVie Inc.
  • ADVANZ PHARMA Corp. Ltd.
  • Biogen Inc.
  • Bristol-Myers Squibb Co.
  • Daiichi Sankyo Co. Ltd.
  • Hikma Pharmaceuticals Plc
  • MORE
The publisher recognizes the following companies as the key players in the global sjogrens syndrome therapeutics market: AbbVie Inc., ADVANZ PHARMA Corp. Ltd., Biogen Inc., Bristol-Myers Squibb Co., Daiichi Sankyo Co. Ltd., Hikma Pharmaceuticals Plc, Johnson & Johnson, Novartis AG, Sanofi SA, and Sun Pharmaceutical Industries Ltd.

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is growing development of biologics'

According to the report, one of the major drivers for this market is the strong drug pipeline.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
4 of 5
  • AbbVie Inc.
  • ADVANZ PHARMA Corp. Ltd.
  • Biogen Inc.
  • Bristol-Myers Squibb Co.
  • Daiichi Sankyo Co. Ltd.
  • Hikma Pharmaceuticals Plc
  • Johnson & Johnson
  • Novartis AG
  • Sanofi SA
  • Sun Pharmaceutical Industries Ltd.
Note: Product cover images may vary from those shown
5 of 5

Loading
LOADING...

Adroll
adroll